Ikarian Capital, LLC

13F Holdings History for Traws Pharma, Inc. - Common Stock, par value $.01 per share (TRAW)

Symbol: TRAW on Nasdaq
Investment type: Equity / Common Stock, par value $.01 per share
Latest Disclosed Ownership: 590K shares
Security Ownership: 9.99%

Shares, Excluding Options vs Price

Value, Excluding Options

Ikarian Capital, LLC ownership in Traws Pharma, Inc. Common Stock, par value $.01 per share (TRAW)

2025-05-15 - Ikarian Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 590K shares of Traws Pharma, Inc. Common Stock, par value $.01 per share (TRAW). This represents 9.99% percent ownership of the company. In their previous filing dated 2025-02-14, Ikarian Capital, LLC had reported owning 394K shares, indicating an increase of 49.5% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Ikarian Capital, LLC	9.99%		$1.16M	590K	+195,247	+49.5%	$1.97	13G/A	3/31/2025	15 May 2025 17:26:46
Ikarian Capital, LLC	9.99%		$777K	394K			$1.97	13G	12/31/2024	14 Feb 2025 13:18:00

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.01%		$42.2K	28.5K			$1.48	Q2 2025
3/31/2025	0.02%	-0.05%	$65.5K	28.5K	-70,000		$2.30	Q1 2025
12/31/2024	0.25%	+0.25%	$875K	98.5K	+98,493	NEW	$8.88	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.